Valuation: Ibnsina Pharma

Market Cap 10.55B 196M 175M 161M 146M 277M 18.36B 284M 1.92B 767M 9.83B 735M 719M 30.96B P/E 2026 *
9.27x
P/E 2027 * 7.09x
Enterprise Value 19.18B 356M 318M 292M 265M 503M 33.37B 515M 3.5B 1.39B 17.87B 1.34B 1.31B 56.27B EV / Sales 2026 *
0.2x
EV / Sales 2027 * 0.17x
Free-Float
58.26%
Yield 2026 *
2.77%
Yield 2027 * 3.92%
1 day+1.06%
1 week+14.55%
Current month+4.80%
1 month-10.51%
3 months-24.02%
6 months-7.35%
Current year-10.67%
1 week 9.7
Extreme 9.7
10.7
1 month 9.02
Extreme 9.02
11.72
Current year 9.02
Extreme 9.02
16.93
1 year 9.02
Extreme 9.02
16.93
3 years 2.14
Extreme 2.14
16.93
5 years 1.1
Extreme 1.101
16.93
10 years 1.1
Extreme 1.101
16.93
Manager TitleAgeSince
Chief Executive Officer - 18/12/2000
Chief Executive Officer - 18/12/2000
Director of Finance/CFO - -
Director TitleAgeSince
Director/Board Member - 18/12/2000
Director/Board Member - 18/12/2000
Director/Board Member - -
Change 5-day change 1-year change 3-year change Capi.($)
+1.06%+14.55%-6.10%+338.08% 196M
-0.37%+6.73%-30.28%+13.63% 17.49B
+0.34%+7.46%-8.71%+15.16% 7.15B
-2.04%+4.30%-7.43%+7.07% 6.97B
+0.33%+3.38%-47.33%-35.28% 6.28B
-6.46%-4.95%+6.93%-15.13% 4.6B
-0.07%-2.63%-29.69%-41.48% 4.69B
-4.42%-0.05%+12.30%-16.57% 3.5B
-1.37%+2.33%-16.55%-18.80% 3.21B
+0.71%+3.00%-15.99%-29.31% 3.19B
Average -1.22%+3.77%-14.29%+21.74% 6B
Weighted average by Cap. -1.11%+4.93%-19.39%-4.11%

Financials

2026 *2027 *
Net sales 94.39B 1.75B 1.56B 1.44B 1.31B 2.47B 164B 2.54B 17.21B 6.86B 87.91B 6.58B 6.43B 277B 103B 1.91B 1.7B 1.57B 1.42B 2.69B 179B 2.76B 18.74B 7.47B 95.72B 7.16B 7.01B 301B
Net income 1.18B 21.95M 19.6M 18.03M 16.37M 31.02M 2.06B 31.79M 216M 85.98M 1.1B 82.4M 80.64M 3.47B 1.58B 29.37M 26.22M 24.12M 21.89M 41.49M 2.75B 42.52M 289M 115M 1.47B 110M 108M 4.64B
Net Debt 8.63B 160M 143M 132M 119M 226M 15.01B 232M 1.57B 627M 8.04B 601M 588M 25.31B 6.81B 126M 113M 104M 94.27M 179M 11.85B 183M 1.24B 495M 6.35B 475M 464M 19.99B
Projected Income Statement - Annual - Ibnsina Pharma
Logo Ibnsina Pharma
Ibnsina Pharma S.A.E. is Egypt's number two in the wholesale distribution of pharmaceutical products. The group offers medicines and cosmetics to more than 35,000 private and public sector customers (distribution chains, pharmacies, wholesalers and health establishments) through 55 sites located in Egypt.
Employees
5,500
Date Price Change Volume
09/11/26 EGP 10.47 +1.06% 9,064,909
08/11/26 EGP 10.36 +0.88% 3,994,224
05/11/26 EGP 10.27 +1.68% 10,171,360
04/11/26 EGP 10.10 +6.88% 19,071,086
03/11/26 EGP 9.450 +3.39% 4,899,189
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - Ibnsina Pharma
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
10.47EGP
Average target price
16.51EGP
Spread / Average Target
+57.66%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Ibnsina Pharma
  1. Stock Market
  2. Stocks
  3. ISPH Stock